What Is NF1 Neurofibromatosis: Causes, Symptoms, Diagnosis, and Treatment

What Is NF1 Neurofibromatosis? Neurofibromatosis type 1 (NF1) is a genetic condition that causes changes in skin pigment and tumors to grow along nerves, and it can affect many parts of the body from skin to the nervous system. You should know that NF1 is common, usually starts in childhood, and often requires ongoing, specialized care rather than a one-time fix.

If you or someone you care about has been diagnosed or you suspect signs like café-au-lait spots, freckling in skin folds, or lumps under the skin, this article will explain how NF1 is identified, why it happens, and what treatments and monitoring can help manage symptoms. Expect clear guidance on what to watch for, how specialists coordinate care, and practical steps to live with NF1.

Understanding NF1 Neurofibromatosis

You will learn what NF1 is, how a change in a single gene causes it, which physical signs and complications commonly appear, and how clinicians confirm the diagnosis.

Definition and Overview

Neurofibromatosis type 1 (NF1) is a genetic condition that primarily causes pigment changes in the skin and growth of tumors along nerves. These tumors are usually benign neurofibromas, but they can cause pain, disfigurement, or functional problems depending on size and location.

NF1 often appears in childhood. Typical early findings include café-au-lait spots and freckling in skin folds. The condition affects about 1 in 2,500 people and occurs equally in males and females.

You should know NF1 varies widely between individuals. Some have mild skin findings only; others develop skeletal issues, learning differences, or tumors affecting the eyes, brain, or spinal cord.

Genetic Causes

NF1 results from a change (mutation) in the NF1 gene located on chromosome 17. The NF1 gene normally produces neurofibromin, a protein that helps regulate cell growth. When neurofibromin is reduced or absent, cells can grow abnormally, forming neurofibromas and other lesions.

About 50% of NF1 cases are inherited in an autosomal dominant pattern. That means a single altered copy of the NF1 gene from one parent can cause the condition. The remaining cases arise from spontaneous (de novo) mutations; neither parent carries the altered gene.

Genetic testing can identify many NF1 mutations, but a negative test does not entirely exclude the diagnosis if clinical features are present. You may discuss targeted testing or full gene sequencing with a genetics specialist depending on your concerns.

Key Symptoms and Signs

Skin findings are the most common and earliest signs. Look for six or more café-au-lait spots larger than 5 mm in young children or larger than 15 mm after puberty, and freckling in the armpits or groin.

Neurofibromas develop under or on the skin and along peripheral nerves. Plexiform neurofibromas are deeper, can be congenital, and may grow extensively, sometimes causing pain or functional impairment. Lisch nodules (iris hamartomas) appear on eye exam and support diagnosis.

Other problems include scoliosis, sphenoid wing dysplasia, short stature, and learning disabilities such as attention or processing issues. Rarely, tumors can become malignant (malignant peripheral nerve sheath tumor), so new pain, rapid growth, or neurologic decline requires urgent evaluation.

Diagnosis Process

Diagnosis primarily relies on established clinical criteria based on physical findings and family history. Meeting two or more specific criteria—such as multiple café-au-lait spots, two or more neurofibromas, plexiform neurofibroma, freckling in axillary or inguinal areas, optic pathway glioma, two or more Lisch nodules, a distinctive bone lesion, or a first-degree relative with NF1—confirms the diagnosis.

Genetic testing for NF1 gene variants supports diagnosis in uncertain cases, in prenatal or reproductive planning, or when atypical features appear. Imaging studies (MRI) help evaluate internal tumors, optic pathway gliomas, or spinal involvement.

You should receive multidisciplinary evaluation: dermatology, neurology, ophthalmology, orthopedics, and genetics as needed. Follow-up plans focus on surveillance for tumor growth, vision changes, learning support, and timely intervention for complications.

Managing and Living With NF1

You will need regular medical follow-up, symptom-directed treatments, and practical supports to manage daily life. Early monitoring and targeted interventions reduce risks from tumors, learning issues, and other complications.

Treatment and Follow-Up Care

Treatment focuses on problems that affect your health or function. You should have baseline and periodic exams with a provider experienced in NF1—typically a geneticist, neurologist, or a multidisciplinary NF clinic.
Surveillance commonly includes annual skin and neurologic exams, blood pressure checks, and growth/learning assessments for children. MRI surveillance is reserved for symptoms or when plexiform neurofibromas (PNs) or optic pathway gliomas are suspected.

Medical and surgical options target specific issues:

• Surgery for symptomatic neurofibromas, spinal tumors, or compressive lesions.
• Selumetinib (a MEK inhibitor) is approved for symptomatic, inoperable plexiform neurofibromas in children and can shrink many tumors.
• Symptom management: pain control, anticonvulsants if seizures occur, and ophthalmology care for vision problems. You should discuss fertility, pregnancy planning, and genetic counseling because NF1 is autosomal dominant.

Potential Complications

NF1 can affect multiple organ systems; early detection prevents lasting harm. Common complications include plexiform neurofibromas that cause pain, disfigurement, or functional loss, and cutaneous neurofibromas that may multiply over time.
Neurologic issues include learning disabilities, attention deficits, seizures, and developmental delays—especially in childhood. You should screen children for school performance and refer to educational services when needed.

Other risks to monitor:

• Optic pathway gliomas—may impair vision, especially in young children.
• Skeletal problems—scoliosis or tibial dysplasia that can cause fractures or limb shortening.
• Hypertension—from renal artery stenosis or pheochromocytoma; check blood pressure routinely.
• Malignant peripheral nerve sheath tumors (MPNSTs)—rare but serious; watch for rapid tumor growth, new pain, or neurological decline and seek urgent evaluation.

Prognosis and Outcomes

Your long-term outlook varies with disease severity and complications. Many people with NF1 lead full lives with normal life expectancy when major complications are absent or effectively managed.
Children identified early for learning support and vision screening often achieve better educational outcomes. Regular tumor surveillance and timely treatment reduce risks of irreversible damage from compressive or malignant tumors.

Factors that worsen prognosis include early-onset large plexiform neurofibromas, recurrent symptomatic tumors, and development of MPNST. Engaging a specialized NF clinic improves access to targeted therapies, clinical trials, and coordinated care, which can positively affect outcomes.

Support Resources

You benefit from medical, educational, and community supports tailored to NF1. Seek a multidisciplinary NF center when possible; these centers coordinate genetics, neurology, surgery, oncology, orthopedics, pain management, and psychosocial care.
Use pragmatic resources:

• Genetic counseling for family planning and testing options.
• Educational plans (IEP/504) for children with learning or attention needs.
• Pain and symptom clinics for chronic pain management.
• Patient advocacy groups for connections, practical guides, and updates on clinical trials.

Keep a personal medical summary with pictures of skin findings, records of tumor imaging, and a list of medications and specialists. That file helps you communicate across providers and speeds urgent evaluations when new symptoms arise.